Search Results - Jonathan Rothberg

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    LAM-003, a new drug for treatment of tyrosine kinase inhibitor–resistant FLT3-ITD–positive AML by Neil Beeharry, Sean Landrette, Sophia Gayle, Marylens Hernandez, Jeff E. Grotzke, Peter R. Young, Paul Beckett, Xuan Zhang, Bing Z. Carter, Michael Andreeff, Stephanie Halene, Tian Xu, Jonathan Rothberg, Henri Lichenstein

    Published in Blood Advances (2019-11-01)
    Get full text
    Article


Search Tools: